ANI Pharmaceuticals to Present at Upcoming Investor Conferences
ANI Pharmaceuticals (NASDAQ:ANIP) has announced its participation in two upcoming investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
ANI Pharmaceuticals (NASDAQ:ANIP) has announced its participation in two upcoming investor conferences. CEO Nikhil Lalwani and the executive team will present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8, 2025, at 9:00 AM ET, and the Morgan Stanley 23rd Annual Global Healthcare Conference on September 9, 2025, at 1:50 PM ET.
Investors can access both live and archived webcasts through the company's website at www.anipharmaceuticals.com in the Investors section under Events and Presentations. The webcast replays will remain available for 90 days.
Details
News Market Reaction – ANIP
On Aug 26, the first trading day after this news, ANIP closed 1.74% above the previous close.
Data tracked by StockTitan Argus for the Aug 26 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PRINCETON, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, along with members of the Company’s executive leadership team will present at two upcoming investor conferences as follows:
EVENT: H.C. Wainwright 27th Annual Global Investment Conference
DATE: Monday, September 8, 2025
TIME: 9:00am ET
EVENT: Morgan Stanley 23rd Annual Global Healthcare Conference
DATE: Tuesday, September 9, 2025
TIME: 1:50pm ET
The live and archived webcasts will be accessible from the Company’s website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 90 days.
About ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Brands business. For more information, visit www.anipharmaceuticals.com.
Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com
Source: ANI Pharmaceuticals, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.